GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (OTCPK:VRCDF) » Definitions » Market Cap

VRCDF (Verici Dx) Market Cap : $7.44 Mil (As of Apr. 04, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Verici Dx Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Verici Dx's share price for the quarter that ended in Jun. 2024 was $0.09. Verici Dx's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 242.54 Mil. Therefore, Verici Dx's market cap for the quarter that ended in Jun. 2024 was $21.83 Mil.

Verici Dx's quarterly market cap declined from Jun. 2023 ($27.42 Mil) to Dec. 2023 ($18.74 Mil) but then increased from Dec. 2023 ($18.74 Mil) to Jun. 2024 ($21.83 Mil).

Verici Dx's annual market cap increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($23.84 Mil) but then declined from Dec. 2022 ($23.84 Mil) to Dec. 2023 ($18.74 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Verici Dx's Enterprise Value for Today is $0.88 Mil.

Verici Dx Market Cap Historical Data

The historical data trend for Verici Dx's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verici Dx Market Cap Chart

Verici Dx Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Market Cap
- - 23.84 18.74

Verici Dx Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Market Cap Get a 7-Day Free Trial 51.10 23.84 27.42 18.74 21.83

Competitive Comparison of Verici Dx's Market Cap

For the Diagnostics & Research subindustry, Verici Dx's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Verici Dx's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Verici Dx's Market Cap distribution charts can be found below:

* The bar in red indicates where Verici Dx's Market Cap falls into.


;
;

Verici Dx Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Verici Dx's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=$0.11*170.319
=$18.74

Verici Dx's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=$0.09*242.541
=$21.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Verici Dx  (OTCPK:VRCDF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Verici Dx Market Cap Related Terms

Thank you for viewing the detailed overview of Verici Dx's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Verici Dx Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (OTCPK:VRCDF) » Definitions » Market Cap
Comparable Companies
LSE:GENI LSE:GDR LSE:PRM LSE:ABDX LSE:LLAI TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD WAT NTRA LH DGX XPAR:BIM ICLR RVTY
Traded in Other Exchanges
VRCI:UK
Address
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Website
https://www.vericidx.com
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies that will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, which of the development of prognostic and diagnostic tests for kidney transplant patients.

Verici Dx Headlines

No Headlines